AABB 2005: new products, techniques and automation on the agenda
This article was originally published in Clinica
Tools for safer blood products, emerging technologies and automation were among the key themes at the annual AABB exhibition and meeting on October 14-18 2005, in Seattle, Washington, which attracted 3% more attendees (7,049), 17% of them hailing from outside the US. HBV NAT and bacterial contamination testing were major topics of discussion from a clinical issues standpoint, and there was much new product approval and launch news during what was an exciting show, writes Kerri Weinert and Carrie Cresenzi, of Boston Biomedical Consultants Inc
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.